Cornea Subspecialty Day 2016
    Cornea/External Disease, Keratoprosthesis

    Dr. Anthony J. Aldave discusses his case series on long-term results of the Boston Keratoprosthesis (B-KPro) type I. A previous retrospective study reported outcomes after an average of 4 years, yet this included cases by multiple physicians at different centers, and patients had a range of indications for the B-KPro. To provide evidence from a single surgeon, Dr. Aldave reviewed outcomes from his own consecutive cases, including 97 eyes of 93 patients. The mean follow-up was 58 months and the most common indications in the cohort were failed corneal transplant, Stevens-Johnson syndrome, and chemical injury. In most patients, visual acuity improved significantly from preoperative values, and the gains were stable for years (up to 10) after implantation. At final follow-up, 83.5% of eyes in this group still had a B-KPro in place, though some underwent replacements.